A. Azuma

发表

2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest.

A. Matsuda, W. Plunkett, P. Huang, 2001, Molecular pharmacology.

S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine.

W. Plunkett, P. Huang, Ye Li, 2001, Cancer research.

Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC).

A. Matsuda, W. Plunkett, P. Huang, 2001, Biochemical pharmacology.

Cellular and Biochemical Mechanisms of the Resistance of Human Cancer Cells to a New Anticancer Ribo‐nucleoside, TAS‐106

M. Fukushima, A. Matsuda, Y. Murakami, 2002, Japanese journal of cancer research : Gann.

Design of New Types of Antitumor Nucleosides: The Synthesis and Antitumor Activity of 2′-Deoxy-(2′-C-Substituted)Cytidines

N. Minakawa, A. Matsuda, A. Dan, 1993 .

Nucleosides and nucleotides. 141. Chemical stability of a new antitumor nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine in alkaline medium: formation of 2'-C-cyano-2'-deoxy-1-beta-D-ribo-pentofuranosylcytosine and its antitumor activity.

A. Matsuda, K. Hanaoka, N. Kamo, 1995, Journal of medicinal chemistry.

Nucleosides and nucleotides. 122. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine and its derivatives. A new class of nucleoside with a broad antitumor spectrum.

N. Minakawa, A. Matsuda, K. Hanaoka, 1993, Journal of medicinal chemistry.

1-(3-C-ETHYNYL-β-D-RIBO-PENTOFURANOSYL)CYTOSINE (ECYD, TAS-106)1: ANTITUMOR EFFECT AND MECHANISM OF ACTION

M. Fukushima, A. Matsuda, Takuma Sasaki, 2001 .

Intracellular Metabolism and Action of an Antitumor Nucleoside, 2′-C-Cyano-2′-Deoxy-1-β-d-arabinofuranosylcytosine (CNDAC)

A. Matsuda, W. Plunkett, Peng Huang, 1997 .

Nucleosides and nucleotides. 100. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-cytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside.

A. Matsuda, Takuma Sasaki, M. Tanaka, 1991, Journal of Medicinal Chemistry.

2′-C-Cyano-2′-deoxy-1-β-D-arabinofuranosylcytosine (CNDAC): A Mechanism-Based DNA-Strand-Breaking Antitumor Nucleoside1

A. Matsuda, A. Azuma, 1995 .

Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation.

A. Matsuda, W. Hittelman, Xiaojun Liu, 2005, Cancer research.

Cloning and expression of uridine/cytidine kinase cDNA from human fibrosarcoma cells.

M. Fukushima, Y. Wataya, A. Matsuda, 2001, International journal of molecular medicine.

Nucleosides and Nucleotides. Part 100. 2′-C-Cyano-2′-deoxy-1-β-D- arabinofuranosylcytosine (CNDAC): Design of a Potential Mechanism- Based DNA-Strand-Breaking Antineoplastic Nucleoside.

A. Matsuda, Takuma Sasaki, M. Tanaka, 1992 .

1‐(3‐C‐Ethynyl‐β‐D‐ribo‐pentofuranosyl)cytosine (ECyd, Tas‐106)1: Antitumor Effect and Mechanism of Action

M. Fukushima, A. Matsuda, Takuma Sasaki, 2001 .

Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'- C-cyano-2'-deoxy-1--

A. Azuma, P. Huang, W. Plunkett, 2001 .